Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, noviembre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Citius Pharmaceuticals Inc
CTXR
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.5107
-0.0081
-1.56%
al cierre: Nov 18, 4:00 PM EST
$0.5000
-0.0107
-2.1%
After hour: 7:12 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Citius Pharmaceuticals Financials
Citius Pharmaceuticals (CTXR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Citius Pharma Q3 EPS $(0.34) Beats $(0.36) Estimate, Sales $1.494M Miss $5.467M Estimate
Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.36) by 5.56 percent. This is a 57.5 percent increase over losses of $(0.80) per share from the
Benzinga Newsdesk
Citius Pharmaceuticals Q1 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Citius Pharma Q1 EPS $(0.38) Misses $(0.30) Estimate, Sales $3.944M Beat $3.455M Estimate
Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.30) by 26.67 percent. This is a 70.77 percent increase over losses of $(1.30) per share from
Benzinga Newsdesk
Gold Edges Lower; Omeros Shares Jump
Avi Kapoor
Dow Gains Over 100 Points; US Jobless Claims Decline
Avi Kapoor
Stock Market Today: Dow Jones, Nasdaq Futures Slip On Christmas Eve Despite Strong Q3 GDP Report— UiPath, AST SpaceMobile, Ramaco In Focus (UPDATED)
(Editor’s note: The future prices of benchmark tracking ETFs and headline were updated in the story.) U.S. stock futures slipped on Wednesday after Tuesday’s higher close. Futures of major benchmark indices fell.
Rishabh Mishra